发明名称 |
Methods of evaluating patients using E-cadherin and vimentin |
摘要 |
Methods for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed. |
申请公布号 |
US9618514(B2) |
申请公布日期 |
2017.04.11 |
申请号 |
US201314428456 |
申请日期 |
2013.09.16 |
申请人 |
AGIOS PHARMACEUTICALS, INC |
发明人 |
Choe Sung Eun;Hurov Jonathan;Ulanet Danielle |
分类号 |
C12Q1/68;G01N33/574;A61K38/50;A61K31/433 |
主分类号 |
C12Q1/68 |
代理机构 |
Lando & Anastasi, LLP |
代理人 |
Lando & Anastasi, LLP |
主权项 |
1. A method of treating a patient having cancer, the method comprising:
acquiring an evaluation of or evaluating a patient sample, wherein the sample is evaluated for i) E-cadherin expression levels and ii) vimentin expression levels; and if E-cadherin expression levels are low, and vimentin expression levels are high, as compared to a reference standard, then
administering to the patient in need thereof a therapeutically effective amount of an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent. |
地址 |
Cambridge MA US |